Open AccessAtorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Author(s) -
Christoph Wanner,
Vera Krane,
Winfried März,
Manfred Olschewski,
Johannes F.E. Mann,
G. Ruf,
Eberhard Ritz
Publication year - 2005
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa043545
Subject(s) - medicine , atorvastatin , hemodialysis , diabetes mellitus , type 2 diabetes mellitus , incidence (geometry) , disease , type 2 diabetes , cardiology , endocrinology , physics , optics
Statins reduce the incidence of cardiovascular events in persons with type 2 diabetes mellitus. However, the benefit of statins in such patients receiving hemodialysis, who are at high risk for cardiovascular disease and death, has not been examined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom